Schmainda KM - Search Results

1

Repeatability of Cerebral Perfusion Using Dynamic Susceptibility Contrast MRI in Glioblastoma Patients.

Jafari-Khouzani K, Emblem KE, Kalpathy-Cramer J, Bjørnerud A, Vangel MG, Gerstner ER, Schmainda KM, Paynabar K, Wu O, Wen PY, Batchelor T, Rosen B, Stufflebeam SM. Jafari-Khouzani K, et al. Among authors: schmainda km. Transl Oncol. 2015 Jun;8(3):137-46. doi: 10.1016/j.tranon.2015.03.002. Transl Oncol. 2015. PMID: 26055170 Free PMC article.

2

Dexamethasone normalizes brain tumor hemodynamics as indicated by dynamic susceptibility contrast MRI perfusion parameters.

Quarles CC, Krouwer HG, Rand SD, Schmainda KM. Quarles CC, et al. Among authors: schmainda km. Technol Cancer Res Treat. 2005 Jun;4(3):245-9. doi: 10.1177/153303460500400303. Technol Cancer Res Treat. 2005. PMID: 15896079 Free article.

3

Assessment of the morphological and functional effects of the anti-angiogenic agent SU11657 on 9L gliosarcoma vasculature using dynamic susceptibility contrast MRI.

Quarles CC, Schmainda KM. Quarles CC, et al. Among authors: schmainda km. Magn Reson Med. 2007 Apr;57(4):680-7. doi: 10.1002/mrm.21193. Magn Reson Med. 2007. PMID: 17390352 Free article.

4

Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors.

Paulson ES, Schmainda KM. Paulson ES, et al. Among authors: schmainda km. Radiology. 2008 Nov;249(2):601-13. doi: 10.1148/radiol.2492071659. Epub 2008 Sep 9. Radiology. 2008. PMID: 18780827 Free PMC article.

5

Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma.

LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM. LaViolette PS, et al. Among authors: schmainda km. Neuro Oncol. 2013 Apr;15(4):442-50. doi: 10.1093/neuonc/nos323. Epub 2013 Feb 3. Neuro Oncol. 2013. PMID: 23382287 Free PMC article.

6

Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma.

Schmainda KM, Prah M, Connelly J, Rand SD, Hoffman RG, Mueller W, Malkin MG. Schmainda KM, et al. Neuro Oncol. 2014 Jun;16(6):880-8. doi: 10.1093/neuonc/not216. Epub 2014 Jan 15. Neuro Oncol. 2014. PMID: 24431219 Free PMC article.

7

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial.

Schmainda KM, Zhang Z, Prah M, Snyder BS, Gilbert MR, Sorensen AG, Barboriak DP, Boxerman JL. Schmainda KM, et al. Neuro Oncol. 2015 Aug;17(8):1148-56. doi: 10.1093/neuonc/nou364. Epub 2015 Feb 2. Neuro Oncol. 2015. PMID: 25646027 Free PMC article. Clinical Trial.

8

Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma.

Prah MA, Stufflebeam SM, Paulson ES, Kalpathy-Cramer J, Gerstner ER, Batchelor TT, Barboriak DP, Rosen BR, Schmainda KM. Prah MA, et al. Among authors: schmainda km. AJNR Am J Neuroradiol. 2015 Sep;36(9):1654-61. doi: 10.3174/ajnr.A4374. Epub 2015 Jun 11. AJNR Am J Neuroradiol. 2015. PMID: 26066626 Free PMC article.

9

Dynamic susceptibility contrast MRI measures of relative cerebral blood volume continue to show promise as an early response marker in the setting of bevacizumab treatment.

Boxerman JL, Schmainda KM, Zhang Z, Barboriak DP. Boxerman JL, et al. Among authors: schmainda km. Neuro Oncol. 2015 Nov;17(11):1538-9. doi: 10.1093/neuonc/nov163. Epub 2015 Sep 11. Neuro Oncol. 2015. PMID: 26361983 Free PMC article. No abstract available.

10

ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.

Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Prah M, Schmainda KM, Mintz A, Kostakoglu L, Eikman EA, Ellingson BM, Ratai EM, Sorensen AG, Barboriak DP, Mankoff DA; ACRIN 6684 Trial Group. Gerstner ER, et al. Among authors: schmainda km. Clin Cancer Res. 2016 Oct 15;22(20):5079-5086. doi: 10.1158/1078-0432.CCR-15-2529. Epub 2016 May 16. Clin Cancer Res. 2016. PMID: 27185374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page